Andrew John Phillips - 05 Apr 2022 Form 3 Insider Report for MoonLake Immunotherapeutics (MLTX)

Role
Director
Signature
/s/ Matthias Bodenstedt, Attorney-in-fact for Andrew John Phillips
Issuer symbol
MLTX
Transactions as of
05 Apr 2022
Net transactions value
$0
Form type
3
Filing time
15 Apr 2022, 16:06:46 UTC
Next filing
05 May 2022
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Andrew John Phillips filed Form 3 for MoonLake Immunotherapeutics (MLTX) on 15 Apr 2022."

Quick Takeaways

  • This page summarizes Andrew John Phillips's Form 3 filing for MoonLake Immunotherapeutics (MLTX).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 15 Apr 2022, 16:06.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney

Sponsored